Interviews

Madiha Iqbal, MD, MBBS, spoke on findings from a study evaluating post-transplantation cyclophosphamide plus sirolimus and how it is associated with a lower risk of chronic GVHD.

Charu Aggarwal, MD, discusses incorporating plasma-based next-generation sequencing to improve guideline-concordant molecular testing in patients with newly diagnosed metastatic nonsquamous NSCLC.

Musa Yilmaz, MD, discusses a highly active triplet combination for patients with FLT3-ITD mutated AML. These data were presented at the 2021 ASCO Annual Meeting.

In this virtual roundtable, Dr Marmarelis convened with Lova Sun, MD, and Hossein Borghaei, DO, to discuss the treatment of patients with lung cancer and KRAS G12C sensitive mutations.

Michael Choi, MD, discusses how to best sequence regimens in the management of patients with CLL. This data was presented at the virtual 2021 LL&M Congress.

Alexey Danilov, MD, PhD, discusses clonal dynamics from the phase 3 CLL14 trial and mechanisms of resistance with venetoclax in patients with CLL at the 2021 virtual LL&M Congress.

During the LL&M Congress, Sham Mailankody, MBBS, discusses when and how to use CAR-T cell therapy for MM.

At the 2021 virtual LL&M Congress, Saad Z. Usmani, MD, MBA, FACP, presents on the therapeutic benefits and methods for management of transplant-ineligible, elderly patients with newly diagnosed MM.

Jonathan L. Kaufman, MD, discusses the role of maintenance therapy in MM; the data of which were presented at the 2021 virtual LL&M Congress.

Kristen Pettit, MD, discusses MDS and highlights if low-risk MDS is really low risk. These data were presented at the virtual 2021 LL&M Congress.